Patents
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
11/2009
11/26/2009WO2009140787A1 Process for production of glycolic acid
11/26/2009WO2009080722A3 Carboxylic derivatives for use in the treatment of cancer
11/26/2009US20090291993 Difluorophenol Derivatives and Their Use
11/26/2009CA2724812A1 Co-crystals of duloxetine and cox-inhibitors for the treatment of pain
11/26/2009CA2723769A1 Anhydrous and hydrate forms of crystalline 2-((2s, 3r, 4e, 6e, 1oe, 12 s)-13-(4-fluorophenoxy)-2,3, 12-(trihydroxytrideca-4, 6, 10-trien-8- ynyl)oxy) acetic acid
11/25/2009EP2123661A1 Chiral iridium aqua complex and method for producing optically active hydroxy compound by using the same
11/25/2009EP2123626A1 Co-crystals of duloxetine and co-crystal formers for the treatment of pain
11/25/2009EP1481961B1 Process for producing (r)-3-hydroxy-3-(2-phenylethyl)hexanoic acid and its intermediate
11/25/2009CN101586129A Method of preparing sodium gluconate from xylose crystallization mother liquor
11/25/2009CN101585764A Method for synthesizing 2-[4-(4-chlorobutyryl)phenyl]-2-methylpropanoic acid
11/25/2009CN101585763A Method for synthesizing 2-[4-(4-chlorobutyryl)phenyl]-2-methylpropanoic acid
11/25/2009CN101585762A Method for synthesizing 2-(4-cyclopropoxycarbonylphenyl)-2-methylpropanoic acid
11/25/2009CN101585761A Industrial continuous preparation method of optically pure mandelic acid
11/25/2009CN100562511C 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
11/19/2009WO2009100989A3 Method for producing 6-hydroxy hexanoic acid esters
11/19/2009US20090287003 Process for the production of intermediates for making prostaglandin derivatives such as latanaprost, travaprost, and bimatoprost
11/19/2009US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/19/2009CA2724271A1 Therapeutic substituted cyclopentanes
11/18/2009CN101583588A Method for producing alkyl polyglycol carboxylic acids and polyglycol dicarboxylic acids
11/18/2009CN101580465A Substituted phenyl keto enols as pesticides and herbicides
11/18/2009CN100560556C Method for synthesizing allyl cyclohexoxyacetate
11/17/2009CA2381351C Process for producing a vic-dichloro acid fluoride
11/12/2009WO2009137066A1 Treprostinil monohydrate
11/12/2009WO2009135977A1 Method for preparing oreganic acid
11/12/2009US20090281199 Cosmetic composition and cosmetic
11/12/2009US20090281189 Treprostinil formulation
11/12/2009US20090281185 Crystalline leukotriene b4
11/12/2009CA2723540A1 Treprostinil monohydrate
11/11/2009EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009CN101575312A Substituted phenyl keto enols as pesticides and herbicides
11/11/2009CN101575283A Method for recycling gulonic acid from vitamin C waste mother liquor
11/11/2009CN100558712C Therapeutic molecules and methods-1
11/10/2009US7615576 Prevention of neutrophil recruitment
11/10/2009US7615575 Compounds for the treatment of metabolic disorders
11/10/2009CA2368652C Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
11/05/2009WO2009134856A2 Pharmaceutical gallium compositions and methods
11/05/2009WO2009102592A3 Epoxidized soyate diesters and methods of using same
11/05/2009US20090275714 New Ruthenium Complexes as Catalysts for Metathesis Reactions
11/05/2009US20090275598 Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
11/05/2009DE102008022017A1 Preparing 1,4-benzothiepin-1,1-dioxide derivative, comprises e.g. reacting mercaptomethyl-hexanol compound with difluorobenzoyl-azinic acid compound and converting into e.g. benzo(b)thiepin-4-ol compound followed by isolating and purifying
11/05/2009CA2722571A1 Pharmaceutical gallium compositions and methods
11/04/2009EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
10/2009
10/29/2009WO2009103534A3 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof
10/29/2009US20090270498 Lipoxin Compounds and Their use in Treating Cell Proliferative Disorders
10/28/2009EP2111399A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
10/28/2009EP2111387A1 New method for preparing unsaturated fatty hydroxy-acids
10/28/2009EP1542957B9 Process for preparing fluorocarboxylic acids
10/28/2009CN101565366A Application of iridium complex in asymmetry catalytic hydrogenation of unsaturated carboxylic acid
10/28/2009CN101565365A Preparation method of alpha, beta-unsaturated acid
10/28/2009CN100554235C Preparation method of alkoxyl mandelic acid
10/27/2009US7608639 Such as 3-{4-[3-(4-Chloro-2- phenoxy-phenoxy)- phenoxy]-2-methyl- phenyl}-propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis
10/27/2009CA2365204C Lipoxin compounds and their use
10/22/2009WO2009127560A1 Intermediates for the preparation of pregabalin and process for their preparation
10/22/2009WO2009097467A3 A functional material and delivery gel composition and method for manufacturing the same
10/21/2009EP2110372A1 Intermediates for the preparation of Pregabalin and process for their preparation
10/21/2009CN101560148A Method for preparing glyoxalic acid by oxidizing glyoxal by chlorine and chlorate
10/21/2009CN101559927A Green technology for synchronously producing chlorine dioxide and glyoxalic acid
10/21/2009CN100551896C Method for preparing 10 - hydroxy capric acid
10/21/2009CN100551893C Method of preparing calcium propionate and calcium lactate with oyster shell as calcium source
10/20/2009US7605182 Compounds that selectively bind to membranes of apoptotic cells
10/20/2009US7605181 Method for the treatment of metabolic disorders
10/15/2009WO2009125606A1 Pai-1 inhibitor
10/15/2009US20090259065 Methods of making organic compounds by metathesis and hydrocyanation
10/15/2009US20090258945 Lipoxin Compounds and Their Use in Treating Cell Proliferative Disorders
10/15/2009CA2720096A1 Pai-1 inhibitor
10/14/2009CN101555239A Method for extracting vitamin C and 2-keto-L-gulonic acid from vitamin C mother liquor
10/14/2009CN101555235A Manufacture process of piperazine ferulate
10/14/2009CN101555212A Synthesized micromolecule compound capable of conveying bioactivator and application thereof
10/14/2009CN101555204A Preparation method of caffeic acid medicinal raw material
10/14/2009CN101555203A Continuous acidolysis method of citrate
10/14/2009CN101555202A Gemfibrozil polymorphism and preparation method thereof
10/14/2009CN101555201A Acidolysis method of L-calcium lactate fermentation solution
10/14/2009CN100548962C Method for preparing hydroxyl conjugated linoleic acid by reduction in alcohol-water system
10/14/2009CN100548960C Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
10/14/2009CN100548955C New photoinitiators
10/08/2009WO2009121940A1 Process for the preparation of (-)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester
10/08/2009US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor
10/07/2009EP2107050A1 Lipoxin compounds
10/07/2009EP1650182B1 Branched carboxylic acid compound and use thereof
10/07/2009EP0741700B1 1-h-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents
10/07/2009CN101553456A Crystalline potassium salt of lipoxin A4 analogs
10/07/2009CN100546969C Process of resolving optical isomer of 2-hydroxmethyl-3-phenylpropionic acid
10/06/2009US7598416 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
10/06/2009US7598292 such as {2-Methyl-4-[2-(4-trifluoromethyl-phenoxymethyl )-allylsulfanyl]-phenoxy}-acetic acid, used as peroxisome proliferator-activated receptors modulators for treating or inhibit the progression of dyslipidemia
10/06/2009US7598289 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
10/06/2009US7598240 Matrix metalloproteinase inhibitors; 4-[2-(hydroxyamino)-2-oxoethyl]-2-[3-(4-methoxyphenyl)propyl]-3-oxo-3,4-dihydro-2H-1,4-benzothiazine-6-carboxylic acid or its ethyl ester; chondrodegenerative diseases or inflammatory diseases such as arthrosis deformans
10/01/2009WO2009119858A1 Benzene compound, and use thereof for medical purposes
10/01/2009US20090247489 Dihydroxyl compounds and compositions for cholesterol management and related uses
09/2009
09/30/2009CN101544638A Lact-pyrondridin and its pharmaceutical composition
09/29/2009US7595412 Reacting an organometallic compound with fatty acid; stabilization of vinyl polymers
09/29/2009US7595341 Analogues of lipid mediators derived from ω-3 PUFAs and methods of use
09/29/2009CA2449800C Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives
09/29/2009CA2418118C Processes for the preparation of fluorinated acyl fluorides and fluorinated vinyl ethers
09/24/2009WO2009115280A1 Remineralizing saliva substitute and method for the production thereof
09/24/2009WO2009115272A1 Remineralizing dental care product and method for the production thereof
09/24/2009US20090239869 Therapeutic substituted cyclopentanes
09/24/2009US20090239146 Non- Aqueous electrolyte secondary battery
09/24/2009US20090238784 Novel Unsaturated Fatty Hydroxy Acid Derivatives and the Dermocosmetologic Use Thereof
09/24/2009DE102008013474A1 Katalytisches Verfahren zur Gewinnung von chemischen Grundstoffen aus nachwachsenden Rohstoffen Catalytic process for the production of basic chemicals from renewable resources
09/23/2009CN101538296A Active ingredients of camptosorus sibiricus, and extraction method and use of same
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 147